Axogen, Inc. (AXGN) is a leading medical technology company specializing in the development and commercialization of innovative surgical solutions for peripheral nerve injuries.
Founded in 2002, Axogen focuses on providing advanced products to help surgeons restore nerve function and improve patient outcomes after traumatic injuries or surgical procedures. The company’s mission is to deliver solutions that enhance the healing process and support nerve repair.
Axogen’s primary products include Avance Nerve Graft, an allograft tissue that provides a biological conduit for nerve regeneration, and Axoguard Nerve Connector, which is designed to facilitate the surgical repair of nerves.
These products are crucial for treating conditions such as carpal tunnel syndrome, nerve transections, and other peripheral nerve injuries. Axogen also offers a range of complementary products that support nerve repair, including nerve wraps and conduits.
The main drivers of growth for Axogen include the increasing incidence of peripheral nerve injuries and the growing awareness among healthcare professionals about the importance of effective nerve repair solutions. As more patients seek treatment for nerve-related conditions, Axogen is well-positioned to capture market share in the expanding field of regenerative medicine.
Additionally, the company’s focus on research and development, along with collaborations with healthcare providers and educational initiatives, supports its strategy to enhance adoption of its products in surgical practices. Learn more at Axogen, Inc..
Click The Image For Current Live Chart